Lucknow Speciality Pharma

Olaparib Tablets 150 mg
Olaparib Tablets is used as maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Your doctor will test for the presence of this gene. To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Olaparib Tablets was approved for medical use in the United States in 2017. It is on the World Health Organization’s List of Essential Medicines. It is available as a generic medication.

Olaparib Tablets Available Price In Lucknow Banaras Nepal

Olaparib Tablets

  • Generic Brand Available – LYNPARZA
  • API – Olaparib
  • Packaging – 7*8 Tablets
  • Strength – 150 mg

What is Olaparib used for?

Olaparib Tablets are used as maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene

About Us

Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

Get Access To Olaparib Tablets 150 mg

Enter Buying Requirements Details

For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

FAQs – Medicine Questions

Olaparib Tablets 150 mg
What is the drug olaparib used for?
Olaparib is used as maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene.
Is olaparib a chemotherapy?
Olaparib is the generic for the trade chemotherapy drug Lynparza™. In some cases, health care professionals may use the trade name Lynparza™ when referring to the generic drug name olaparib. Drug type: Olaparib is a targeted therapy.
How quickly does olaparib work?
It takes Lynparza between two months and five months to start working depending on what cancer it is being used to treat. It may take at least 3 months for Lynparza to start working when used to treat ovarian cancer
Where can I buy Olaparib Tablets?

You can buy Olaparib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Olaparib Tablets?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com  Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Olaparib Tablets price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

How good is olaparib?
Olaparib has demonstrated stable response in diseases like ovarian cancer, breast cancer, and gastric cancer, and its efficacy seems more marked in patients with BRCA-mutation tumors. A previous meta-analysis demonstrated that the use of olaparib could improve PFS, but showed no significant efficacy in OS.

NEWS / UPDATES

  1. AstraZeneca UK Limited, Electronic medicines compendium (emc), [Revised on Jan 2021] [ Accessed on 2nd Dec 2021], https://www.medicines.org.uk/emc/files/pil.9204.pdf
  2. AstraZeneca Pharmaceuticals LP, US Food and Drug Administration, [Revised on Jan 2018] [ Accessed on 2nd Dec 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208558s001lbl.pdf
  3. Sylvia Bochum, Stephanie Berger, Uwe M Martens; Olaparib; Recent Results in Cancer Research; Published on 2018; Accessed on 02/12/2021; https://pubmed.ncbi.nlm.nih.gov/30069770/
  4. Xiao Xia Guo et al; The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials; Cancer Management and Research; Published on Aug 2018; Accessed on 02/12/2021; https://pubmed.ncbi.nlm.nih.gov/30127642/